No Data
No Data
No Data
No Data
No Data
Pioneer Pharmaceutical Biotech announced that the placement agreement has expired and that the placement matters will not be carried out
Pilot Pharmaceutical Biotechnology (00399) issued an announcement. Since the prerequisites contained in the placement agreement were not fully reached or satisfied before April 18, 2024 (that is, the final deadline of the placement agreement), the placement agreement has expired and the placement matters will not proceed. All rights, obligations and liabilities of the contracting party to the placement agreement will cease and end, and the contracting party will not file any claims against the other party, except for any prior breach of the placement agreement before the termination of the placement agreement. The announcement stated that the expiration of the placement agreement will not have any significant adverse impact on the company's current operations and financial situation.
新浪港股Apr 21 20:42 ET
Pioneer Pharmaceutical Biotechnology (00399.HK): The placement agreement has expired
Gelonghui, April 19 | Pilot Pharmaceutical Biotechnology (00399.HK) announced that since the prerequisites contained in the placement agreement were not fully reached or satisfied before April 18, 2024, the placement agreement has expired and the placement matters will not proceed.
Gelonghui FinanceApr 19 08:37 ET
Pilot Pharmaceutical Biotechnology (00399) issued 55 million shares due to the exercise of the right to convert convertible bonds
Pilot Pharmaceutical Biotechnology (00399) issued an announcement according to the exercise of convertible shares issued on April 30, 2015...
Zhitong FinanceJan 10 05:53 ET
Pilot Pharmaceutical Biotechnology (00399) issued approximately 99 million shares due to the conversion of convertible bonds
Pilot Pharmaceutical Biotechnology (00399) issued an announcement. The company issued on December 31, 2014 in accordance with the exercise...
Zhitong FinanceJan 5 06:08 ET
Innovative Pharmaceutical Biotech (HKG:399) Is Posting Solid Earnings, But It Is Not All Good News
Solid profit numbers didn't seem to be enough to please Innovative Pharmaceutical Biotech Limited's (HKG:399) shareholders. Our analysis suggests they may be concerned about some underlying details.
Simply Wall StJan 4 19:25 ET
領航醫藥生物科技:中期報告 2023-2024
Futu NewsDec 28, 2023 05:07 ET · Announcements
No Data
No Data